fashion -WSS

fashion

author：focus 2025-09-03 03:29:02 - browse：7

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： UnitedHealth quietly bought dozens of outpatient centers

WSS

'Revelatory' study finds a smoking impact that remains after quitting

UnitedHealth quietly bought dozens of outpatient centers

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

The dental labor crisis is a moment of opportunity

'Revelatory' study finds a smoking impact that remains after quitting

KalVista pill reduced swelling 'attacks' caused by genetic disease

explore

fashion

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CDC marks new Covid

Drug repurposing or repositioning? The language matters

Gilead might be held responsible for not developing a drug

Jerome Adams on the need for new antivirals for Covid

Vaccine advisory panel ACIP left half staffed by HHS

At least 13 dead in Texas as scorching temps continue

Former medical device CEO who sold dummy, plastic parts convicted of fraud

The cancer drug shortage isn’t new — and neither are the solutions

Air quality improving but still lags in Black, Hispanic communities

explore

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Biogen Alzheimer’s drug launch off to slow start

Just how do doctors, lawmakers, and the public define abortion?

NEJM study link tiny plastics in blood vessels to heart problems

Industry veterans launch new biotech VC with $310M

Biogen Alzheimer’s drug launch off to slow start

knowledge

explore

entertainment

hotspot